Clinical trial: Esophageal Cancer, (NCT03081715)

Cancer research · Esophageal cancer

This study will evaluate the safety of PD-1 knockout engineered T cells in treating advanced esophageal cancer.

This study will evaluate the safety of PD-1 knockout engineered T cells in treating advanced esophageal cancer. Blood or tissue samples will also be collected for research purposes.

Evidence level: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.

Original source

Related signals

• Esophageal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
• Clinical Trials Update in Resectable Esophageal Cancer
• Advances in targeted therapy for esophageal cancer
• A review of esophageal cancer research: emerging trends, progress and perspectives
• An esophageal cancer clinical trial - ES3